Clinical Trials Logo

Clinical Trial Summary

To demonstrate that clear, interpretable quality images of the ovaries and uterus can be generated using a portable transvaginal ultrasound scanner in the home environment, and that those images are interpretable by physicians with sufficient clarity to estimate approximate antral follicle count (i.e., appropriate for age) and to observe submucosal fibroids. Study aims to prove that images taken when ultrasound is performed by a woman herself (with HCP supervision via telemedicine) and images taken when ultrasound is administered by an HCP are of comparable quality. Study population reflects real-world patient characteristics and includes both general-population and submucosal fibroid positive controls.


Clinical Trial Description

Today, pro-fertility information is generally unavailable to healthy women; clinically meaningful in-clinic testing is limited by physician availability and patient willingness to undergo testing in-clinic, while home testing is limited to hormonal bloodwork which is insufficient on its own and has high false positives. Sponsor is developing home telemedicine transvaginal ultrasound as part of a home fertility assessment. Sponsor wishes to demonstrate the ability to obtain interpretable images, in women of varying body habitus, reproductive age, and reproductive status. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04687189
Study type Interventional
Source Turtle Health, Inc.
Contact
Status Completed
Phase N/A
Start date February 27, 2021
Completion date April 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT05443698 - SELF-GYN1 (Sonograms Enable Looking Forward- Get Your iNformation 1 Trial) N/A
Withdrawn NCT05509322 - Care Expansion Across Remote Environments - Sub-Study of the SELF-GYN1 Trial N/A
Completed NCT04784325 - Anti-Mullerian Hormone - At My Home N/A